This single-institution pilot study uses a pre- and post-implementation design to evaluate the implementation of ICG fluorescent imaging for sentinel lymph node biopsy (SLNB) in an Italian hospital.
Clinically node-negative, DCIS or invasive stage T1-T3 breast cancer confirmed by biopsy
Preoperative axillary ultrasound to confirm clinical node-negative status
Indication for breast cancer surgery with SLNB via axillar incision
Written informed consent according to national regulations
Patients < 18 years old.
Indication for breast cancer surgery with SLNB via mastectomy incision
Known allergy for ICG, intravenous contrast or iodine
History of axillary lymph node dissection